John Bencich - 16 Aug 2024 Form 4 Insider Report for ACHIEVE LIFE SCIENCES, INC. (ACHV)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
20 Aug 2024, 16:05:33 UTC
Prior SEC filing
23 Apr 2024
Next SEC filing
03 Apr 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Sandra Thomson as attorney-in-fact for John Bencich

Key filing fact

John Bencich filed Form 4 for ACHIEVE LIFE SCIENCES, INC. (ACHV) on 20 Aug 2024.

Key facts

  • This page summarizes John Bencich's Form 4 filing for ACHIEVE LIFE SCIENCES, INC. (ACHV).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 20 Aug 2024, 16:05.

Change

  • Previous filing in this sequence was filed on 23 Apr 2024.
  • Current net transaction value: +$18,350.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ACHV transaction

Common Stock

Award

Transaction value
$18,350
Shares
+5,000
Change %
+5.2%
Price
$3.67
Shares after
100,636
Date
16 Aug 2024
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents shares of common stock acquired under the Issuer's 2017 Employee Stock Purchase Plan.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .